cancer
Last updated: 2024-12-04

Saisei Mirai Group: Japan's Largest Regenerative Medicine & GcMAF Research Network

S
Medical Supporter Team
Cross-border medical coordination and editorial review team
Saisei Mirai Group: Japan's Largest Regenerative Medicine & GcMAF Research Network

Saisei Mirai Group: Japan's Largest Regenerative Medicine & GcMAF Research Network

Medical Supporter — Information Notice

This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.

Any specific treatment plan must be assessed by a licensed physician in Japan

Director saiseiDirector saisei

Saisei Mirai Group is the largest medical group in Japan's regenerative medicine field with significant R&D strength. The group collaborates with several university laboratories, dedicated to applying advanced cell regulation technology to cancer auxiliary nurturing care and refractory disease repair.


[Medical Supporter Guardian Statement] Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Considering medical care in Japan? Need information and support?

We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.

Fukuoka HQ: +81-92-984-3200
Formerly officially certified, No. B-066

Related Reading